Bellevue Group AG

SEC CIK: 0001674546
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overview All 13F holders of BMRN Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 20; Since Q1 2021

Holdings of BMRN by Bellevue Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−65,008−100.0%	Sold out	Holders
Q4 2025	65,008	$3.86M	0.1%	−36,025−35.7%	Reduced	Holders
Q3 2025	101,033	$5.47M	0.1%	−50,412−33.3%	Reduced	Holders
Q2 2025	151,445	$8.32M	0.2%	−216,928−58.9%	Reduced	Holders
Q1 2025	368,373	$26.0M	0.6%	+39,352+12.0%	Added	Holders
Q4 2024	329,021	$21.6M	0.4%	−1,955−0.6%	Reduced	Holders
Q3 2024	330,976	$23.3M	0.4%	+278,744+533.7%	Added	Holders
Q2 2024	52,232	$4.30M	0.1%	−269,555−83.8%	Reduced	Holders
Q1 2024	321,787	$28.1M	0.4%	−3,989−1.2%	Reduced	Holders
Q4 2023	325,776	$31.4M	0.5%	−24,112−6.9%	Reduced	Holders
Q3 2023	349,888	$31.0M	0.5%	−10,716−3.0%	Reduced	Holders
Q2 2023	360,604	$31.3M	0.4%	+312,159+644.4%	Added	Holders
Q1 2023	48,445	$4.71M	0.1%	−12,240−20.2%	Reduced	Holders
Q4 2022	60,685	$6.28M	0.1%	+7,192+13.4%	Added	Holders
Q3 2022	53,493	$4.54M	0.1%	−20,260−27.5%	Reduced	Holders
Q2 2022	73,753	$6.11M	0.1%	−847−1.1%	Reduced	Holders
Q1 2022	74,600	$5.75M	0.1%	+3,200+4.5%	Added	Holders
Q4 2021	71,400	$6.31M	0.1%	+19,700+38.1%	Added	Holders
Q3 2021	51,700	$4.00M	<0.1%	+11,200+27.7%	Added	Holders
Q2 2021	40,500	$3.38M	<0.1%	+3,500+9.5%	Added	Holders
Q1 2021	37,000	$2.79M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.